Faculty profile

Eytan Wine

ResearcherPediatricsUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Eytan Wine

Researcher

Pediatrics

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
77 publications in the last five years, latest in 2026.
Senior (last) author on 18 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2019.
Supervisor on 1 trainee award (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

147

Publications

535

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Host-Microbe Interactions Inflammatory Bowel Diseases Pediatrics Ulcerative Colitis Pathobionts Gut Microbes Immunoglobulin G Metabolomics

Latest papers

Machine Learning Predicts First Elective Bowel Resection in Newly Diagnosed Pediatric Crohn Disease Patients.
Journal of pediatric surgery · 2026 · senior author
Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls.
Crohn's & colitis 360 · 2026
Enhanced Energy Metabolism and Developmental Signaling in Neonatal Brains of Female Piglets Parenterally Fed with 18-Carbon n-3 Fatty Acid-Based Vegaven Compared with Fish Oil-Containing Lipid Emulsion.
Current developments in nutrition · 2026

All 147 publications

Latest funding

Defining the molecular mechanisms underlying how consumption of specific ultra processed foods impacts disease progression, risk of surgery and post-operative recurrence in the CIDsCaNN Canadian national pediatric Crohn's disease cohort
CIHR · 2026 · Co-investigator
$10,000
Vegaven, a novel lipid emulsion with unique superior biological actions designed for parenteral nutrition
CIHR · 2023 · Co-investigator
$818,550
Microbial Causes of Ulcerative Colitis: Looking Outside the Involved Region
CIHR · 2019 · Nominated PI
$895,050

All 5 grants and awards

147 publications.

Machine Learning Predicts First Elective Bowel Resection in Newly Diagnosed Pediatric Crohn Disease Patients.

Suarez Suarez RG, Parsaee A, Ahmed S, Huynh HQ, Shaikh A, Otley A, Jacobson K, Sherlock M, Mack DR, Deslandres C, El-Matary W, Crowley E, deBruyn J, Benchimol EI, Walters T, Griffiths AM, Greiner R, Wine E, Canadian Children IBD Network

Journal of pediatric surgery2026Senior author

DOI: 10.1016/j.jpedsurg.2026.163488 PMID: 42767336

Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls.

Sigall-Boneh R, Organ S, Ghiboub M, Yanai H, Abramas L, Wierdsma N, Verburgt CM, de Jonge WJ, Derikx JPM, Lewis JD, Gu H, Bielawski J, Maharshak N, Dotan I, Wine E, Dunn K, Van Limbergen J

Crohn's & colitis 3602026

DOI: 10.1093/crocol/otag071 PMID: 42491760

Enhanced Energy Metabolism and Developmental Signaling in Neonatal Brains of Female Piglets Parenterally Fed with 18-Carbon n-3 Fatty Acid-Based Vegaven Compared with Fish Oil-Containing Lipid Emulsion.

Lucchinetti E, Lou PH, Wang F, Pauline ML, Alam M, Wizzard PR, Patel Z, Tan Q, Nation PN, Field CJ, Wine E, Krämer SD, Wales PW, Turner JM, Zaugg M

Current developments in nutrition2026

DOI: 10.1016/j.cdnut.2026.109400 PMID: 42438771

Host-microbe interactions in the appendix of children with inflammatory bowel diseases.

Arjomand Fard N, Githaka JM, Veniamin S, Guan LL, Aujla H, Kaur A, Lerner EP, Zaidi D, Armet AM, Andrews J, Han X, Vallance BA, Madsen KL, Perry T, Wine E

American journal of physiology. Gastrointestinal and liver physiology2026Senior author

DOI: 10.1152/ajpgi.00080.2026 PMID: 42531280

The Impact of Integrating Pelvic Magnetic Resonance Imaging at Diagnosis on Early Detection of Perianal Crohn's Disease in Pediatrics.

Antaya M, Hudson AS, Lerner EP, Nasser K, Carroll MW, Isaac DM, Wine E, Perry T, Thompson A, Huynh HQ

The American journal of gastroenterology2026

DOI: 10.14309/ajg.0000000000003733 PMID: 40834290

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort.

Ricciuto A, Turinsky AL, Griffiths AM, Mack DR, Wine E, Benchimol EI, El-Matary W, Huynh HQ, Carman N, deBruyn JC, Otley AR, Church PC, Jacobson K, Low S, Broer E, Lawrence S, Sherlock M, Deslandres C, Walters TD, Canadian Children IBD Network

Inflammatory bowel diseases2026

DOI: 10.1093/ibd/izaf329 PMID: 41671043

Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study.

Suarez RG, Bar Or O, Orlanski-Meyer E, Shavit Z, Azulay A, Broide E, Urlep D, Kastl A, Hyams JS, Levine J, Rosh J, Russell RK, Turner D, Wine E

Inflammatory bowel diseases2026Senior author

DOI: 10.1093/ibd/izag154 PMID: 42566304

Nutrition care and dietetic resources in pediatric inflammatory bowel disease: An initiative of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Porto Group and Special Interest Group.

Boneh RS, Oren N, Wine E, Shouval DS, Russell RK, Martín-de-Carpi J, Gerasimidis K

Journal of pediatric gastroenterology and nutrition2026

DOI: 10.1002/jpn3.70343 PMID: 41766607

Early proactive therapeutic drug monitoring with ustekinumab therapy in pediatric Crohn's disease: data from the prospective Canadian children IBD network.

Ricciuto A, McKay HE, deBruyn JC, Crowley E, Church PC, Huynh HQ, Otley AR, Shaikh A, Mack DR, Carman N, El-Matary W, Schneider R, Wine E, Walters TD, Griffiths AM, Canadian Children IBD Network

Crohn's & colitis 3602026

DOI: 10.1093/crocol/otag019 PMID: 41890638

Early intestinal ultrasound findings predict remission and treatment response at 1 year in pediatric Crohn's disease.

Hudson AS, Isaac DM, Ma H, Kuc A, Carroll MW, Wine E, Huynh HQ

Journal of Crohn's & colitis2026

DOI: 10.1093/ecco-jcc/jjag036 PMID: 41866919

Something wrong or missing on this profile? Suggest a correction

Eytan Wine

Research

Latest papers

Latest funding

Machine Learning Predicts First Elective Bowel Resection in Newly Diagnosed Pediatric Crohn Disease Patients.

Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls.

Enhanced Energy Metabolism and Developmental Signaling in Neonatal Brains of Female Piglets Parenterally Fed with 18-Carbon n-3 Fatty Acid-Based Vegaven Compared with Fish Oil-Containing Lipid Emulsion.

Host-microbe interactions in the appendix of children with inflammatory bowel diseases.

The Impact of Integrating Pelvic Magnetic Resonance Imaging at Diagnosis on Early Detection of Perianal Crohn's Disease in Pediatrics.

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort.

Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study.

Nutrition care and dietetic resources in pediatric inflammatory bowel disease: An initiative of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Porto Group and Special Interest Group.

Early proactive therapeutic drug monitoring with ustekinumab therapy in pediatric Crohn's disease: data from the prospective Canadian children IBD network.

Early intestinal ultrasound findings predict remission and treatment response at 1&#xa0;year in pediatric Crohn's disease.

Defining the molecular mechanisms underlying how consumption of specific ultra processed foods impacts disease progression, risk of surgery and post-operative recurrence in the CIDsCaNN Canadian national pediatric Crohn's disease cohort

Vegaven, a novel lipid emulsion with unique superior biological actions designed for parenteral nutrition

Microbial Causes of Ulcerative Colitis: Looking Outside the Involved Region

Microbial Causes of Ulcerative Colitis: Looking Outside the Involved Region

Pro-inflammatory role of dietary fibers in IBD: defining how microbes mediate diet-associated inflammation and could guide diet-based therapies

Frequent collaborators

Heather Armstrong

Eytan Wine

Amanda Ricciuto

Anthony Otley

Heather Armstrong

Karen Madsen

Troy Perry

Andrew Mason

Johan Van Limbergen

Mary Zachos

Nikhil Pai

Michael Zaugg

Farhad Peerani

Wael Elhenawy

Pierre Boulanger

Jens Walter

Herbert Brill

Michael Surette

David Mack

Aleixo Muise

Anne Griffiths

David Armstrong

Noelle Rohatinsky

Justin Chun

Remo Panaccione

Luis Murguia-Favela

Kate Lee

Richard Fedorak

Dina Kao

Karen Kroeker

Robert Bandsma

Eytan Wine

Early intestinal ultrasound findings predict remission and treatment response at 1 year in pediatric Crohn's disease.